News

In people with SM, mast cells may contribute to anemia by breaking down red blood cells.

Cogent Bioscience announced that their trial of bezuclastinib in patients with advanced SM showed the drug to be safe and effective.

Gastrointestinal mastocytosis occurs in about one-third of patients with systemic mastocytosis and strongly predicts bone marrow involvement.

A true diagnosis of mast cell diseases like SM requires specific clinical, biochemical and molecular criteria, researchers stress.

The treatment of bone disease associated with SM requires measures that target the mast cells that drive disease processes.

A CME intervention led to significant improvements in allergists’ knowledge and confidence in diagnosing and managing SM, study finds.

An unusual case of anaphylaxis following ackee fruit ingestion led to the unexpected diagnosis of indolent systemic mastocytosis (SM).

High-throughput proteomics and machine learning helped uncover new protein signatures with useful prognostic implications in SM.

Patients with indolent SM who took avapritinib saw significant improvements in itching, flushing and skin spots that lasted for three years.

A recent case report shows how inconclusive early testing led to a delayed diagnosis of indolent SM marked by chronic anaphylaxis.